Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsAlessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.Pediatric Blood & Cancer|January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority TrialRoberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcomaElena Palassini, Sara Pizzamiglio, Emanuela Palmerini, et al.Journal of Translational Medicine|October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-worldPatrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2022
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II TrialPaolo A Ascierto, Mario Mandalà, Pier Francesso Ferrucci, et al.Cancer|October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trialSandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.European Journal of Cancer (Oxford, England : 1990)|May 14, 2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma StudyIvar Hompland, Stefano Ferrari, Stefan Bielack, et al.Critical Reviews in Oncology/Hematology|May 8, 2026
Management of Atypical Cartilaginous Tumors (ACT) An Italian Sarcoma Group Consensus DocumentDomenico A Campanacci, Giacomo Giulio Baldi, Roberto Scanferla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) TrialsEmanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.Pageof 12